Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shionogi & Co ( (JP:4507) ) has provided an announcement.
Shionogi & Co., Ltd. has completed the disposal of 200,400 treasury shares as part of a restricted stock compensation plan, with a total value of approximately ¥500 million. This move is aimed at aligning the interests of directors and officers with the company’s performance, potentially impacting the company’s governance and stakeholder relations.
The most recent analyst rating on (JP:4507) stock is a Hold with a Yen2750.00 price target. To see the full list of analyst forecasts on Shionogi & Co stock, see the JP:4507 Stock Forecast page.
More about Shionogi & Co
Shionogi & Co., Ltd. is a pharmaceutical company based in Osaka, Japan, primarily focused on developing and marketing pharmaceutical products. The company is known for its contributions to the healthcare industry, particularly in the areas of infectious diseases and pain management.
Average Trading Volume: 2,429,785
Technical Sentiment Signal: Buy
Current Market Cap: Yen2189.6B
For an in-depth examination of 4507 stock, go to TipRanks’ Overview page.